TOP PAGE
ENGLISH
JAPANESE
|
CONNECT WITH US:
Home
About
Services
Contact
Log in
*
Home
Press release
Dec 21, 2018 10:00 JST
Source:
NutraLife Biosciences, Inc.
Legalization of Industrial Hemp Positions NutraFuels for Market Expansion
Coconut Creek, FL, Dec 21, 2018 - (ACN Newswire) - via NEWMEDIAWIRE -- NutraFuels, Inc (NTFU) applauds the passage of the 2018 Farm Bill allowing federally insured banks to legally work with merchants for product processing as well as the removal of barriers for research and industrial hemp production.
"The hemp industry has been challenged over the years because of banking restrictions. It has caused challenges from the standpoint of merchant product processing for hemp-derived CBD products. It also caused headwinds with respect to many aspects of the companies operating in the hemp public markets," said Edgar Ward, CEO and Founder of NutraFuels.
Brightfield Group estimates the worth of the hemp CBD market to be $22 Billion by 2022, outpacing the rest of the cannabis market combined. "We've been planning and preparing for an increase in CBD product demand in anticipation of the passage of the 2018 Farm Bill," added Ward.
The updated language from the Farm Bill defines hemp in a way that removes it from the Controlled Substances Act. Going forward, hemp will be classified as an agricultural commodity under federal law. Farmers will now benefit from the removal of barriers to obtaining crop insurance. Shareholders and manufacturers will see the removal of restrictions on importing and exporting hemp which contributes to the projected boost of growth for the hemp industry.
"The lack of legal clarification and the longtime stigma around hemp has dampened the business opportunity and created concern for the investment community," said Ward. "The new law provides clarity and the legal parameters to enable companies like NutraFuels to capitalize on a more efficient operating environment and market expansion."
NutraFuels (www.nutrafuels.com) is a fully reporting company in a class of securities registered with the SEC. The Company's filings can be viewed at www.sec.gov. NTFU's CBD products and information about the company's direct sales program can be found at www.nutrahempcbd.com and by following the company on Instagram.
Edgar Ward
+1-561-212-3816
edgar@nutrafuels.com
Forward Looking Statements
This communication contains statements of a forward-looking nature. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by words or phrases such as "may," "will," "except," "anticipate," "aim," "estimate," "intend," "plan," "believe," "is/are likely to," "future" or other similar expressions. The Company has based these forward-looking statements largely on the Company's current expectations and projections about future events and financial trends that the Company believes may affect Company's financial condition, results of operations, business strategy, and financial needs. There is no assurance that Company's current expectations and projections are accurate. All forward-looking statements in this press release are based on information available to the Company on the date hereof. These statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to differ materially from those implied by the forward-looking statements. More detailed information about these risk factors are set forth in the Company's filings with the Securities and Exchange Commission, including, but not limited to, those risks and uncertainties listed in the section entitled "Risk Factors," in the Company's Annual Report on Form 10-K with the Securities and Exchange Commission on April 17, 2018. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company's management to predict all risk factors, nor can the Company assess the impact of all factors on Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking statement. The Company does not undertake any obligation to update or revise the forward-looking statements except as required under applicable law.
Source: NutraLife Biosciences, Inc.
Sectors: Agritech, Food & Beverage, BioTech, Healthcare & Pharm, Funds & Equities
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Related Press Release
NutraLife Biosciences, Inc. enters Joint Venture with Henning Trading LLC to Cultivate and Process Hemp for 2019 U.S. Grow Season
April 12 2019 07:20 JST
NutraLife Bioscience, Inc. Reports 2018 Year End Financial Results
April 04 2019 05:00 JST
NutraLife Biosciences Encouraged By CVS Health Corporation's Decision to Distribute CBD at 800 Stores in the U.S.
March 25 2019 05:00 JST
NutraLife Bioscience, Inc. Receives License to Grow and Process Industrial Hemp
March 15 2019 05:00 JST
NutraLife Biosciences, Inc. Receives Contract to Provide Its Technologies and Delivery System for Pharmaceutical Products by cGMP Pharmacy
March 13 2019 05:00 JST
NutraFuels, Inc. Explores New Delivery Systems with Pharmaceutical GMP Manufacturer
March 01 2019 21:00 JST
NutraFuels, Inc. Tests Confirm High Quality Proprietary Ultra Shear Technology Platform
February 25 2019 09:00 JST
NutraFuels, Inc. Founds NutraDerma Technologies and Acquires Patented All-Natural Skin Patch for Deet-free Mosquito Deterrent
February 13 2019 08:00 JST
NutraFuels and Pressure BioSciences to Collaborate on the Development of Water-Soluble Nanoemulsion-based Nutraceuticals
January 30 2019 22:00 JST
NutraFuels, Inc Takes Strides to Becoming Fully-Integrated in the Hemp-Derived CBD Sector, Forms Strategic Partnership with Maryland Based Botanical Products Processor
November 21 2018 08:00 JST
More Press release >>
Latest Press Release
HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion
Dec 12, 2025 23:15 JST
Anime Tokyo Station: A Series of Linked Events to Be Held in Conjunction with the Anniversary Joint Exhibition
Dec 12, 2025 11:00 JST
MHI and Worley to Deliver Full-Scale Carbon Capture Facility for Heidelberg Materials UK's Padeswood Cement Works
Dec 08, 2025 17:00 JST
Honda Technical Support for Red Bull Powertrains in F1 Racing Concludes
Dec 08, 2025 16:34 JST
MHIET U.S. Subsidiary's Franklin Plant Celebrates 10th Anniversary
Dec 08, 2025 16:03 JST
Lexus World Premieres Lexus LFA Concept BEV Sports Car
Dec 05, 2025 19:13 JST
TOYOTA GAZOO Racing World Premieres GR GT & GR GT3
Dec 05, 2025 18:58 JST
TOYOTA GAZOO Racing and Lexus Hold World Premiere of GR GT, GR GT3, and Lexus LFA Concept
Dec 05, 2025 18:24 JST
World's First General Design Approval (GDA) for Developed Steel and Post-Weld Heat Treatment (PWHT) Exemption based on ECA for Low-pressure Liquefied CO2 Tank made of KF460 steel
Dec 05, 2025 18:17 JST
Hitachi at CES 2026: Building a Harmonized Society Through Technology
Dec 04, 2025 19:40 JST
Fujitsu and Scaleway partner to accelerate European sustainable transformation and data sovereignty with FUJITSU-MONAKA CPU-based AI inference
Dec 04, 2025 19:08 JST
NEC Orchestrating Future Fund Invests in PopID, Inc. to Accelerate Global Expansion of Biometric Payment Solutions and Launch a Strategic Collaboration
Dec 04, 2025 18:52 JST
Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI(R) (lecanemab-irmb) Maintenance Treatment in Early Alzheimer's Disease at CTAD 2025
Dec 04, 2025 18:36 JST
The 26th Hong Kong Forum marks successful completion
Dec 03, 2025 22:44 JST
New Data Presented at CTAD 2025 Confirms Pharmacological Effect of LEQEMBI(R) (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF
Dec 03, 2025 18:19 JST
Mitsubishi Motors Launches the All-New Destinator in Vietnam
Dec 03, 2025 18:00 JST
Anime Tokyo Station: Celebrating the 25th Anniversaries of Two Popular Anime with an Anniversary Joint Exhibition Starting November 15
Dec 03, 2025 11:30 JST
Eisai Presents New Data on Anti-Tau Antibody Etalanetug (E2814) at CTAD 2025
Dec 03, 2025 00:01 JST
NEC Launches AI Agent Service in Japan to Automate Procurement Negotiations Using AI
Dec 02, 2025 23:43 JST
Fujitsu develops new technology to support human-robot collaboration
Dec 02, 2025 23:26 JST
More Latest Release >>